miR-192 enhances sensitivity of methotrexate drug to MG-63 osteosarcoma cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

miR-192 enhances sensitivity of methotrexate drug to MG-63 osteosarcoma cancer cells

Published:2020-11 Issue:11 Volume:216 Page:153176
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Bazavar Mohammadreza,Fazli Jafar,Valizadeh Amir,Ma Binfang,Mohammadi Erfan,Asemi Zatollah,Alemi Forough,Maleki Masoomeh,Xing Shilong,Yousefi Bahman

Funder

Tabriz University of Medical Sciences

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference33 articles.

1. miR-223-3p inhibits human osteosarcoma metastasis and progression by directly targeting CDH6;Ji;Mol. Ther.,2018

2. Analyzing the interactions of mRNAs and ncRNAs to predict competing endogenous RNA networks in osteosarcoma chemo-resistance;Zhu;Mol. Ther.,2019

3. MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression;Osaki;Mol. Ther.,2011

4. miR-491 inhibits osteosarcoma lung metastasis and chemoresistance by targeting αB-crystallin;Wang;Mol. Ther.,2017

5. Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells;Song;Mol. Cancer,2010

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate cancer and the cell cycle: Focusing on the role of microRNAs;Gene;2024-11

2. Deciphering chemoresistance in osteosarcoma: Unveiling regulatory mechanisms and function through the lens of noncoding RNA;Drug Development Research;2024-03-05

3. miRNA-Based Technologies in Cancer Therapy;Journal of Personalized Medicine;2023-11-09

4. From resistance to resilience: Uncovering chemotherapeutic resistance mechanisms; insights from established models;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11

5. miRNAs as potential game-changers in bone diseases: Future medicinal and clinical uses;Pathology - Research and Practice;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3